Doctorate at The First Affiliated Hospital of Chongqing Medical University | China
Dr. Xinmiao Lu’s work exemplifies innovation, clinical relevance, and translational potential in molecular imaging and diagnostics. Her research on cutting-edge tools for cancer theranostics and in vitro diagnostics highlights her contributions to improving patient outcomes and advancing medical science.
Professional Profiles
Scopus
Orcid
🎓 Academic and Professional Background
Dr. Xinmiao Lu is an accomplished academic and researcher with extensive training and expertise. He earned master’s degree under the guidance of Prof. Lan Zhang at the University of Chinese Academy of Sciences and completed her doctoral studies at Shanghai Jiao Tong University under the mentorship of Prof. Xinyuan Zhu and Prof. Peiyong Li, where he was recognized as an Outstanding Graduate of Shanghai. Following a productive postdoctoral tenure at Shanghai Jiao Tong University, he joined the First Affiliated Hospital of Chongqing Medical University as an Assistant Professor dedicated to full-time scientific research.
🔬 Areas of Research Focus
Dr. Lu’s research focuses on innovative molecular imaging technologies, with an emphasis on developing advanced molecular probes and devices. His primary interest lies in creating new molecular tools such as PET/SPECT radiopharmaceuticals for precise and early cancer theranostics. Impressively, two of he developed tools are progressing to clinical trials, underscoring their practical potential in transforming cancer diagnosis and treatment.
🧪 Innovations in Molecular Diagnostics
Beyond in vivo applications, Dr. Lu has significantly contributed to in vitro diagnostic tools. He has developed fluorescent probes and liquid biopsy magnetic beads, enhancing diagnostic accuracy. Notably, he work on magnetic beads was successfully commercialized and integrated into an IVD (In Vitro Diagnostics) company, marking a substantial impact on the healthcare industry.
🏆 Research Publications and Recognition
Dr. Lu’s groundbreaking research has been published in prestigious journals, including the Chemical Engineering Journal, Journal of Medicinal Chemistry (as a cover article), Analytical Chemistry, Journal of Nanobiotechnology, and European Journal of Medicinal Chemistry. These publications reflect her dedication to advancing the field of molecular imaging and diagnostics and her ability to address complex healthcare challenges with innovative solutions.
Publications Top Noted📝
Construction of in-situ self-assembled agent for NIR/PET dual-modal imaging and photodynamic therapy for hepatocellular cancer
Authors: Lu, X.; Fu, Y.; Zhu, Y.; Luo, Q.; Pang, H.
Journal: Journal of Nanobiotechnology
Year: 2024
Construction and Preliminary Evaluation of Two 18F-Labeled Radiopharmaceuticals for Myocardial Perfusion Imaging
Authors: Lu, X.; Deng, X.; Kong, F.; Hai, W.; Luo, Q.
Journal: Analytical Chemistry
Year: 2024
Development of a Supermolecular Radionuclide-Drug Conjugate System for Integrated Radiotheranostics for Non-small Cell Lung Cancer
Authors: Lu, X.; Zhu, Y.; Deng, X.; Luo, Q.; Zhu, X.
Journal: Journal of Medicinal Chemistry
Year: 2024
Construction of a Cu2+-Responsive NIR Fluorescent Probe and the Preliminary Evaluation of its Multifunctional Application
Authors: Zhang, T.; Chi, H.; Guo, J.; Lu, X.; Li, G.
Journal: Journal of Fluorescence
Year: 2024
Development of a NIR fluorescent probe for fluorescence-assisted EGFR-TKI applicable patients screening and drug resistance monitoring
Authors: Lu, X.; Wu, M.; Luo, Q.
Journal: European Journal of Medicinal Chemistry
Year: 2023